Veterinarians use medetomidine as a sedative and an anesthetic. Although it’s only approved for veterinary use, this substance is often mixed with fentanyl, opioids and illicit drugs, causing longer-lasting effects and severe withdrawal symptoms.
Although medetomidine contains dexmedetomidine, it’s only approved for use in animals. In contrast, hospitals use dexmedetomidine in humans in operating rooms, emergency departments and intensive care units as a sedative or pain reliever. On the streets, medetomidine is known as “rhino tranq.”
Medetomidine is classified as an αlpah2-adrenergic (a2-adrenergic) receptor agonist, so it causes profound sedation, slows down the heart and lowers blood pressure significantly. It first made its way into street drugs in 2022, but spiked in 2024, with an increase of 29% to 87% in samples tested between May and November 2024. The lack of research on the use of medetomidine in humans makes it extremely dangerous.
Due to the potential for harm, it’s essential to know the side effects of medetomidine, signs and symptoms of dependence and potential risks of abuse. On this page, you’ll learn about medetomidine itself, not general veterinary sedatives or the mixing of medetomidine with other substances.
